Clinical Trials Directory

Trials / Unknown

UnknownNCT05967832

Contribution of 7 Tesla MRI of the Hypothalamus in the Diagnosis of Type 1 Narcolepsy

Contribution of 7 Tesla MRI of the Hypothalamus in the Diagnosis of Type 1 Narcolepsy: Pilot Study

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
30 (estimated)
Sponsor
Assistance Publique Hopitaux De Marseille · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

This study is part of the research on type 1 narcolepsy, a neurological pathology affecting mostly young subjects. The only biomarker currently available is the hypocretin assay, which shows a level below 110 pg/mL. However, the interpretation of this biomarker has limitations: the test is not widely available and it is rarely performed by practitioners. Even when performed, the interpretation of the level may not be consistent with the phenotype compatible with type 1 narcolepsy. This study therefore aims to develop new tools to reduce the diagnostic delay. This would be the first study with 7T MRI that could achieve a level of spatial resolution sufficient to highlight volume changes in small brain structures such as the lateral hypothalamus whose narcolepsy-induced changes are not detected by lower resolution MRI.

Conditions

Interventions

TypeNameDescription
OTHER7T MRIPatients and healthy volunteers will have a 7T MRI

Timeline

Start date
2024-01-29
Primary completion
2026-01-29
Completion
2026-01-29
First posted
2023-08-01
Last updated
2024-02-01

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT05967832. Inclusion in this directory is not an endorsement.